Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 3:36 pm Purchase | 13G | NeuroPace Inc NPCE | Soleus Private Equity Fund I L.P. | 2,433,168 8.200% | 400 (+0.02%) | View |
2024-10-02 4:30 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 1,237,909 2.560% | -1,410,563 (-53.26%) | View |
2024-09-06 4:59 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 2,648,472 5.500% | -1,252,842 (-32.11%) | View |
2024-04-16 09:15 am Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 3,901,314 8.100% | -319,083 (-7.56%) | View |
2024-02-02 09:20 am Purchase | 13G | NeuroPace Inc NPCE | Soleus Private Equity Fund I L.P. | 2,432,768 9.300% | 63,765 (+2.69%) | View |
2023-02-14 08:22 am Purchase | 13G | NeuroPace Inc NPCE | Soleus Private Equity Fund I L.P. | 2,369,003 9.500% | 60,000 (+2.60%) | View |
2023-01-09 5:00 pm Purchase | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 4,220,397 9.200% | 1,972,873 (+87.78%) | View |
2022-02-10 5:02 pm Sale | 13G | GALECTO INC GLTO | Soleus Private Equity Fund I L.P. | 0 0.000% | -1,512,648 (Position Closed) | View |
2022-02-10 5:00 pm Purchase | 13G | NeuroPace Inc NPCE | Soleus Private Equity Fund I L.P. | 2,309,003 9.500% | 473,663 (+25.81%) | View |
2021-11-01 5:16 pm Purchase | 13G | NeuroPace Inc NPCE | Soleus Private Equity Fund I L.P. | 1,835,340 7.600% | 1,835,340 (New Position) | View |
2021-09-03 5:16 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 2,247,524 6.950% | -546,709 (-19.57%) | View |
2021-06-28 4:32 pm Sale | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 2,794,233 8.690% | -400,000 (-12.52%) | View |
2021-02-12 5:12 pm Sale | 13G | GALECTO INC GLTO | Soleus Private Equity Fund I L.P. | 1,512,648 5.990% | -5,400 (-0.36%) | View |
2020-12-28 4:30 pm Purchase | 13D | BIOATLA INC BCAB | Soleus Private Equity Fund I L.P. | 3,194,233 9.930% | 3,194,233 (New Position) | View |
2020-11-12 09:02 am Purchase | 13G | GALECTO INC GLTO | Soleus Private Equity Fund I L.P. | 1,518,048 6.170% | 1,518,048 (New Position) | View |